Latest Acquisition News

Flight Centre Travel Group has reported a record total transaction value of $24.5 billion for FY25, yet underlying profits fell slightly short of expectations amid geopolitical tensions and regional challenges. The company is banking on new AI and loyalty initiatives to drive future growth.

Advance Metals reports robust exploration results with standout gold grades at Myrtleford and significant silver-gold intersections at Yoquivo, while advancing acquisitions that broaden its Mexican portfolio.

Larvotto Resources has given the final nod to develop its Hillgrove Antimony-Gold Project in NSW, fully funded and moving into construction with production set for mid-2026.

EV Resources has secured a 70% stake in the Los Lirios Antimony Project, unveiling high-grade mineralisation and plans for a pilot plant to accelerate production. Leadership enhancements and portfolio rationalisation underscore its strategic pivot to critical minerals.

Loyal Metals has secured an option to acquire the world-class Highway Reward Copper-Gold Mine and is progressing its North American lithium assets, supported by $3.77 million in funding.

Kingfisher Mining has secured a strategic acquisition of copper-gold and base metal projects in NSW from Austin Metals, backed by a $1.85 million capital raise, while progressing high-grade rare earth and lithium exploration in Western Australia.

Medallion Metals has amended terms to acquire 100% of Forrestania Nickel Operation assets, while progressing strong drilling results and financing discussions at Ravensthorpe Gold Project, positioning for a Final Investment Decision in late 2025.

Capricorn Metals has agreed to acquire the Mongers Lake Project adjacent to its Mt Gibson Gold Project, aiming to unlock new gold resources in Western Australia. The $1.5 million deal includes cash and shares, with milestone payments tied to resource and mining developments.

XPON Technologies reported a strong Q4 FY25 with a 27% revenue jump driven by its Alpha Digital acquisition, while targeting positive EBITDA and cash flow from Q2 FY26.

Red Hill Minerals reported robust royalty revenues and exploration progress in the June 2025 quarter, underpinned by strong iron ore shipments and strategic royalty acquisitions. The company’s solid cash position and advancing drill programs position it well for growth.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir ahead of schedule, setting sights on expedited FDA approval leveraging the Animal Rule.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology candidate, completed FDA IND transfer, and plans to launch phase II trials in 2026. The company also reported a solid cash position and issued loyalty options to shareholders.